February 23, 2017
FPMAJ Drug Pricing Affairs Chief Yoshiaki Kamoya (left) at Chuikyo Subcommittee Meeting It is “not very appropriate” to apply the foreign price adjustment rule to new drugs that have similar products in terms of indications and pharmacological action already on...read more